Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 6/20 | 1.00 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.62 |
| ▸ | OPRL1 | P41146 | 5/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.48 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.45 |
| ▸ | CCR5 | P51681 | 2/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9495770 | 0.77 | MCHR1 (0.65) | BACE1OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL10148843 | 0.75 | BACE1 (0.60) | BACE1OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL10148844 | 0.75 | BACE1 (0.60) | BACE1OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL592802 | 0.70 | BACE1 (0.54) | BACE1OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL660567 | 0.70 | MCHR1 (0.57) | BACE1OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL8812119 | 0.70 | MCHR1 (0.57) | BACE1OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL8435318 | 0.69 | GAA (0.55) | BACE1 | |
| SCHEMBL2993642 | 0.69 | OPRL1 (0.55) | BACE1OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL7841441 | 0.68 | MCHR1 (0.59) | BACE1OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL8209542 | 0.68 | BACE1 (0.67) | BACE1BACE2OPRL1OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5221675-A | Aza-spirocyclic compounds that enhance cholinergic neurotransmission | ABBOTT LABORATORIES (US) | 1993-06-22 | — | — | US | disclosed |